BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Montero D, Lundby C. Reduced arteriovenous oxygen difference in heart failure with preserved ejection fraction patients: Is the muscle oxidative phenotype certainly involved? Eur J Prev Cardiolog 2017;24:1157-60. [DOI: 10.1177/2047487317706587] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Tsujimoto T, Kajio H. Efficacy of renin-angiotensin system inhibitors for patients with heart failure with preserved ejection fraction and mild to moderate chronic kidney disease. Eur J Prev Cardiol 2018;25:1268-77. [PMID: 29808753 DOI: 10.1177/2047487318780035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
2 Piepoli MF, Spoletini I, Rosano G. Monitoring functional capacity in heart failure. Eur Heart J Suppl 2019;21:M9-M12. [PMID: 31908608 DOI: 10.1093/eurheartj/suz216] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Nashawi M, Sheikh O, Battisha A, Mir M, Chilton R. Beyond the myocardium? SGLT2 inhibitors target peripheral components of reduced oxygen flux in the diabetic patient with heart failure with preserved ejection fraction. Heart Fail Rev 2020. [PMID: 32583230 DOI: 10.1007/s10741-020-09996-y] [Reference Citation Analysis]
4 Montero D, Haider T, Barthelmes J, Goetze JP, Cantatore S, Sudano I, Ruschitzka F, Flammer AJ. Hypovolemia and reduced hemoglobin mass in patients with heart failure and preserved ejection fraction. Physiol Rep 2019;7:e14222. [PMID: 31724335 DOI: 10.14814/phy2.14222] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
5 Aimo A, Castiglione V, Borrelli C, Saccaro LF, Franzini M, Masi S, Emdin M, Giannoni A. Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies. Eur J Prev Cardiolog 2020;27:494-510. [DOI: 10.1177/2047487319870344] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 10.0] [Reference Citation Analysis]
6 Milinković I, Polovina M, Simeunović DS, Ašanin M, Seferović PM. Oxidative stress and inflammation in heart failure: The best is yet to come. Eur J Prev Cardiol 2020;27:490-3. [PMID: 32013599 DOI: 10.1177/2047487319900294] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Montero D, Diaz-Cañestro C. Determinants of exercise intolerance in heart failure with preserved ejection fraction: A systematic review and meta-analysis. Int J Cardiol 2018;254:224-9. [PMID: 29407095 DOI: 10.1016/j.ijcard.2017.10.114] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]